Companion Diagnostics Market by Product & Service (Assay, Kit, Software & Service), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung & Colorectal Cancer, Cardiovascular Disease), End-User (Pharma Companies, CRO), Region - Global Forecast to 2024

Publisher Name :
Date: 16-Sep-2019
No. of pages: 240
Inquire Before Buying

“The companion diagnostics market is estimated to grow at a CAGR of 15.7%”

The companion diagnostics market is projected to reach 7.3 billion by 2024 from USD 3.5 billion in 2019, at a CAGR of 15.7%. The growth of the companion diagnostics industry is tied primarily to its various advantages, the growing need for targeted therapy, the increasing importance of personalized medicine. Moreover, the increasing global incidence of cancer, ever-increasing application areas of companion diagnostics, rising demand for next-generation sequencing, the growing significance of companion diagnostics in drug development, and the increasing number of clinical trials are expected to present growth opportunities for players in the market. However, the high cost of companion diagnostic tests and the uncertain reimbursement scenario in different regions affect market growth to a certain extent during the forecast period.

“Cancer segment to witness the highest growth during the forecast period”

The cancer segment is estimated to grow at the highest CAGR during the forecast period. This can be attributed primarily to the increasing global incidence of cancer, the growing role of companion diagnostics in personalized medicine treatment for cancer, the rising utility of biomarkers in the diagnosis of cancer, technological advancements in cancer diagnostics at the molecular level, and the availability of funding for cancer research.  

“Pharmaceutical & biopharmaceutical companies segment to grow at the highest CAGR in the companion diagnostics market, by end-user”

The major factors driving the demand for pharmaceutical & biopharmaceutical companies in companion diagnostics are growing prominence in drug development and the growing importance of companion diagnostic biomarkers. The increasing demand for personalized medicine as well as the high demand for targeted therapies for various diseases and disorders are also expected to drive the demand and uptake of companion diagnostics among pharmaceutical & biopharmaceutical companies.

“APAC market to witness the highest growth during the forecast period”

Asia Pacific is estimated to be the fastest-growing regional market for companion diagnostics during the forecast period. The high incidence of cancer, growing proteomics & genomics research, increasing research funding, rising investments by pharmaceutical and biotechnology companies, and growing awareness about personalized therapeutics in several APAC countries are some of the major factors driving the growth of this market.

A breakdown of the primary participants in this report is provided below:

By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%

By Designation: C-level–35%, Director Level–25%, and Others–40%

By Region: North America–45%, Europe–20%, Asia Pacific–30%, Rest of the World (RoW)–5%

The prominent players operating in the global companion diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (US), QIAGEN N.V. (Germany), Abbott Laboratories, Inc. (US), Almac Group (UK), Danaher Corporation (US), Illumina, Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc., (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), Abnova Corporation (Taiwan), and Guardant Health, Inc. (US).

Research Coverage:

This report analyzes the market for various companion diagnostics and their adoption patterns. It aims at estimating the size and future growth potential of the global companion diagnostics market as well as its segments (by product & service, technology, indication, end-user, and region). The report also includes an in-depth competitive analysis of key market players along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or any combination of the below mentioned five strategies for strengthening their market presence.


  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global companion diagnostics market

  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and service launches in the global companion diagnostics market

  • Market Development: Comprehensive information on the lucrative emerging regions

  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global companion diagnostics market

  • Competitive Assessment: In-depth assessment of product offered, market shares, growth strategies, and revenue analysis of leading players in the global companion diagnostics market

Companion Diagnostics Market by Product & Service (Assay, Kit, Software & Service), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung & Colorectal Cancer, Cardiovascular Disease), End-User (Pharma Companies, CRO), Region - Global Forecast to 2024

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Companion Diagnostics: Market Overview
4.2 Asia Pacific: Companion Diagnostics Market, By End User (2018)
4.3 Regional Mix: Companion Diagnostics Market
4.4 Companion Diagnostics Market: Developing Vs. Developed Countries
4.5 Geographical Snapshot of the Companion Diagnostics Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advantages of Companion Diagnostics
5.2.1.2 Growing Need for Targeted Therapy
5.2.1.3 Growing Importance of Personalized Medicine
5.2.1.4 Increasing Global Incidence of Cancer
5.2.1.5 Growing Application Areas of Companion Diagnostics
5.2.2 Restraints
5.2.2.1 High Cost of Companion Diagnostic Tests
5.2.2.2 Uncertain Reimbursement Scenario in Different Regions
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Next-Generation Sequencing
5.2.3.2 Growing Significance of Companion Diagnostics in Drug Development
5.2.3.3 Increasing Number of Clinical Trials
5.2.4 Challenges
5.2.4.1 Shortage of Trained Professionals

6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Focus on Liquid Biopsy in Companion Diagnostics
6.2.2 Increasing Collaborations
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 US
6.3.1.2 Canada
6.3.2 Europe
6.3.3 APAC
6.3.3.1 Australia
6.3.3.2 Japan
6.3.3.3 China
6.3.3.4 India
6.3.4 Brazil
6.4 Product Pipeline Analysis

7 Companion Diagnostics Market, By Product & Service
7.1 Introduction
7.2 Assays, Kits, & Reagents
7.2.1 With the Growing Need for Personalized Medicine, the Volume of Companion Diagnostic Tests Performed in Laboratories is Increasing, Which Supports the Adoption of Assays & Kits
7.3 Software & Services
7.3.1 the Need for Effective Data Management Software Within Laboratories is Increasing, Contributing to the Growth of the Companion Diagnostic Software & Services Market

8 Companion Diagnostics Market, By Technology
8.1 Introduction
8.2 Polymerase Chain Reaction (PCR)
8.2.1 Growing Applications of PCR Technologies in the Field of Personalized Medicine and Companion Diagnostics Drive the Growth of This Segment
8.3 Next-Generation Sequencing (NGS)
8.3.1 the NGS Segment is Expected to Grow at the Highest CAGR During the Forecast Period
8.4 in Situ Hybridization (ISH)
8.4.1 Increasing Adoption of ISH is Mainly Due to Advancements in Hybridization and Its Demand in Small-Tumor Diagnostics
8.5 Immunohistochemistry (IHC)
8.5.1 Increasing Demand for USer-Friendly and Cost-Effective Technologies in Companion Diagnostics to Drive the Growth of This Segment
8.6 Other Technologies

9 Companion Diagnostics Market, By Indication
9.1 Introduction
9.2 Cancer
9.2.1 Breast Cancer
9.2.1.1 Breast Cancer is the Most Common Cancer Among Women—A Key Factor Contributing to the Large Share of This Market Segment
9.2.2 Lung Cancer
9.2.2.1 Growing Demand for Therapeutic Drugs and Their High EffiCACy in the Treatment of Lung Cancer Increase the Adoption of Companion Diagnostics in This Segment
9.2.3 Colorectal Cancer
9.2.3.1 Growing Need for Molecular Profiling of Primary Tumors in Colorectal Cancer to Drive Growth in This Market Segment
9.2.4 Melanoma
9.2.5 Gastric Cancer
9.2.5.1 Increasing Focus of Market Players on the Development of Tests and Kits for Gastric Cancer Indications to Drive Market Growth
9.3 Neurological Diseases
9.3.1 Growing Number of Diagnostic Technologies for the Treatment of Neurological Diseases to Boost the Adoption of Companion Diagnostics in This Segment
9.4 Infectious Diseases
9.4.1 Growing Focus of Companion Diagnostic Players on Orphan Indications to Propel the Growth of This Segment During the Forecast Period
9.5 Cardiovascular Diseases
9.5.1 Growing Demand for Targeted Therapies Due to High Incidence and Mortality Rate of Cardiovascular Diseases to Drive Growth in This Segment
9.6 Other Indications

10 Companion Diagnostics Market, By End User
10.1 Introduction
10.2 Pharmaceutical & Biopharmaceutical Companies
10.2.1 Wide Usage of Companion Diagnostics in Pharmaceutical & Biopharmaceutical Companies Owing to Their Growing Prominence in Drug Development to Drive Market Growth
10.3 Reference Laboratories
10.3.1 Growing Incidence of Diseases Such as Cancer and the Rising Demand for Targeted Therapies to Drive the Growth of This End-User Segment
10.4 Contract Research Organizations
10.4.1 Cros Offer a Complete Range of Companion Diagnostic Services Ranging From Companion Diagnostic Development to Targeted Therapy-Related Clinical Trials
10.5 Other End Users

11 Companion Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 US is the Largest Market for Companion Diagnostics in North America
11.2.2 Canada
11.2.2.1 Government Initiatives to Promote Companion Diagnostics in Various Indications are Expected to Drive Market Growth in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Germany is a Major Market for Pharmaceutical and Biotechnology Products in Europe
11.3.2 UK
11.3.2.1 Growth in the Country’s Life Science Industry and Increasing Research are Key Factors Driving Market Growth in the UK
11.3.3 Switzerland
11.3.3.1 Switzerland Boasts a Strong Research-Oriented Pharma Industry
11.3.4 France
11.3.4.1 Increasing Government Funding for Genomics and Personalized Therapeutics R&D is Driving Market Growth
11.3.5 Italy
11.3.5.1 Growing Disease Prevalence has Contributed to the Demand for Better, More Powerful Therapeutics in Italy
11.3.6 Spain
11.3.6.1 Medical Institutes in Spain are Increasingly Focusing on Cancer Biomarker Research
11.3.7 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.1.1 Japan Holds the Largest Share of the Market in Apac
11.4.2 China
11.4.2.1 China is One of the Most Prominent Research Markets, Worldwide
11.4.3 India
11.4.3.1 Indian Government has Focused on Tackling the Problem of a Growing Cancer Incidence
11.4.4 Australia
11.4.4.1 Rising Burden of Geriatric Population has Resulted in Initiatives to Enhance Healthcare Access and Infrastructure
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.1.1 Brazil Dominates the Latin American Companion Diagnostics Market
11.5.2 Mexico
11.5.2.1 Mexico is Emerging as a Prominent Medical Tourism Hub
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 Rising Cancer Incidence Rate has Attracted Stakeholder Attention to Regional Markets in Mea

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Leadership Mapping, 2018
12.4 Vendor Inclusion Criteria
12.5 Vendor Dive
12.5.1 Visionary Leaders
12.5.2 Innovators
12.5.3 Emerging Companies
12.5.4 Dynamic Differentiators
12.6 Competitive Situations and Trends
12.6.1 Partnerships, Collaboration, and Agreements
12.6.2 Acquisitions

13 Company Profiles
13.1 F. Hoffmann-La Roche AG
13.1.1 Business Overview
13.1.2 Products Offered
13.1.3 Recent Developments
13.1.4 MnM View
13.2 Agilent Technologies, Inc.
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.3 QIAGEN N.V.
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Abbott Laboratories, Inc.
13.4.1 Business Overview
13.4.2 Product Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Almac Group
13.5.1 Business Overview
13.5.2 Services Offered
13.5.3 Recent Developments
13.5.4 MnM View
13.6 Danaher Corporation
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM View
13.7 Illumina Inc.
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.7.4 MnM View
13.8 bioMérieux SA
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 MnM View
13.9 Myriad Genetics, Inc.
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Recent Developments
13.9.4 MnM View
13.10 Sysmex Corporation
13.10.1 Business Overview
13.10.2 Products and Services Offered
13.10.3 Recent Developments
13.10.4 MnM View
13.11 Thermo Fisher Scientific, Inc.
13.11.1 Business Overview
13.11.2 Products & Services Offered
13.11.3 Recent Developments
13.11.4 MnM View
13.12 Abnova Corporation
13.12.1 Business Overview
13.12.2 Services Offered
13.12.3 Recent Developments
13.12.4 MnM View
13.13 Guardant Health, Inc.
13.13.1 Business Overview
13.13.2 Products Offered
13.13.3 Recent Developments
13.13.4 MnM View

14 Appendix
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Available Customizations
14.5 Related Reports
14.6 Author Details

  • In Vitro Diagnostics Companies in China
    Published: 11-Oct-2019        Price: US 1800 Onwards        Pages: 52
    This study focuses on China's In Vitro Diagnostics industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumption......
  • In Vitro Diagnostics Industry Forecasts - China Focus
    Published: 11-Oct-2019        Price: US 1800 Onwards        Pages: 94
    This study focuses on China's In Vitro Diagnostics industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services......
  • In Vitro Diagnostics Markets in China
    Published: 11-Oct-2019        Price: US 4000 Onwards        Pages: 198
    China's demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ......
  • Global Companion Diagnostic Market Professional Survey Report 2019
    Published: 09-Oct-2019        Price: US 3500 Onwards        Pages: 101
    A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy. The global ......
  • Global D-Dimer Testing Industry Market Research Report
    Published: 08-Oct-2019        Price: US 2960 Onwards        Pages: 136
    The D-Dimer Testing market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the D-Dimer Testing industrial chain, this report mainly elaborates the definition, types, applications and major players of D-Dimer Testing market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry developme......
  • Global Companion Diagnostic Industry Market Research Report
    Published: 08-Oct-2019        Price: US 2960 Onwards        Pages: 123
    The Companion Diagnostic market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Companion Diagnostic industrial chain, this report mainly elaborates the definition, types, applications and major players of Companion Diagnostic market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, ind......
  • Global and China Prenatal Genetic Testing Market Research by Company, Type & Application 2013-2025
    Published: 05-Oct-2019        Price: US 2000 Onwards        Pages: 71
    Summary Market Segment as follows: By Type - Diagnostic Test - Chorionic Villi Sampling (CVS) - Amniocentesis - Placental Biopsy - Cordocentesis - Fetal Biopsy - Screening Test - Carrier Screening - Sequential Screening - Maternal Serum Quad Screening By Application - Hospitals - Clinics - Diagnostic Centers By Company - Sequenom Laborat......
  • Global and China Preimplantation Genetic Diagnosis Market Research by Company, Type & Application 2013-2025
    Published: 27-Sep-2019        Price: US 2000 Onwards        Pages: 73
    Summary Market Segment as follows: By Type - Genetic Diagnosis - Genetic Screening By Application - Fertility Clinics - Research By Company - Illumina, Inc. - Thermo Fisher Scientific Inc. - Agilent Technologies, Inc. - Perkinelmer, Inc. - Coopersurgical - ABBott Laboratories - Natera, Inc. - Rubicon Genomics - Oxford Gene Technology - Yikon Genomi......
  • Global Drug Of Abuse Testing Industry Market Research Report
    Published: 26-Sep-2019        Price: US 2960 Onwards        Pages: 134
    The Drug Of Abuse Testing market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Drug Of Abuse Testing industrial chain, this report mainly elaborates the definition, types, applications and major players of Drug Of Abuse Testing market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs